Advanced
  Home Compare Reports

Comparison with Similar Reports

Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forens...

Publisher:        MarketsandMarkets

# of Pages:        231

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 MARKET SCOPE 32
1.2.2 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.3 MARKETS COVERED 33
FIGURE 1 BIOINFORMATICS SERVICES MARKET SEGMENTATION 33
1.2.4 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
TABLE 1 STANDARD CURRENCY CONVERSION RATES 34
1.4 LIMITATIONS 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.2 RESEARCH APPROACH 37
FIGURE 2 BIOINFORMATICS SERVICES MARKET: RESEARCH DESIGN METHODOLOGY 37
2.2.1 SECONDARY DATA 38
2.2.2 PRIMARY DATA 38
FIGURE 3 PRIMARY SOURCES 39
2.2.2.1 Key data from primary sources 40
2.2.2.2 Key industry insights 41
FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.3 MARKET ESTIMATION METHODOLOGY 42
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 43
FIGURE 6 MARKET SIZE ESTIMATION: BIOINFORMATICS SERVICES
MARKET (BOTTOM-UP APPROACH) 44
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 8 TOP-DOWN APPROACH 45
2.4 COVID-19 HEALTH ASSESSMENT 46
2.5 COVID-19 ECONOMIC ASSESSMENT 46
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 46
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 47
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 48
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE BIOINFORMATICS SERVICES MARKET 48
2.8 DATA TRIANGULATION 49
FIGURE 11 DATA TRIANGULATION 49
2.9 RESEARCH ASSUMPTIONS 50
2.10 RISK ANALYSIS 50
3 EXECUTIVE SUMMARY 51
FIGURE 12 BIOINFORMATICS SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 51
FIGURE 13 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2021 VS. 2026 (USD MILLION) 52
FIGURE 14 BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 52
FIGURE 15 BIOINFORMATICS SERVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 BIOINFORMATICS SERVICES MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 54
4 PREMIUM INSIGHTS 55
4.1 BIOINFORMATICS SERVICES MARKET OVERVIEW 55
FIGURE 17 GROWING APPLICATIONS OF BIOINFORMATICS TO DRIVE
THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD 55
4.2 BIOINFORMATICS SERVICES MARKET, BY TYPE 56
FIGURE 18 SEQUENCING SERVICES SEGMENT WILL CONTINUE TO DOMINATE THE BIOINFORMATICS SERVICES MARKET BY 2026 56
4.3 ASIA PACIFIC BIOINFORMATICS SERVICES MARKET, BY COUNTRY AND APPLICATION 57
FIGURE 19 GENOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOINFORMATICS SERVICES MARKET 57
4.4 BIOINFORMATICS SERVICES MARKET, BY END USER 58
FIGURE 20 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE
THE LARGEST END USERS OF BIOINFORMATICS SERVICES 58
4.5 BIOINFORMATICS SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 21 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 22 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Growing applications of bioinformatics in various industries 60
5.2.1.2 Increasing public-private sector funding for bioinformatics services 60
TABLE 2 PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS 60
5.2.1.3 Shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects 63
5.2.1.4 Increasing pharmaceutical and biotech R&D expenditure 63
TABLE 3 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE ASIA PACIFIC REGION 64
5.2.2 RESTRAINTS 64
5.2.2.1 In-house development of bioinformatics solutions and publicly available bioinformatics tools 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 Reducing cost of sequencing and growing volume of data generated during sequencing 65
FIGURE 23 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2019 65
FIGURE 24 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–2019 66
5.2.3.2 Growing focus on outsourcing for the management
of large volumes of data 66
5.2.3.3 Growth potential in emerging economies 67
5.2.4 CHALLENGES 67
5.2.4.1 Complexity of data 67
5.2.4.2 Lack of well-defined standards and interoperability issues for bioinformatics analysis 67
5.2.4.3 Ethical issues 68
5.2.5 INDUSTRY TRENDS 68
5.2.5.1 Partnerships & collaborations for technological advancements in the bioinformatics services market 68
FIGURE 25 ECOSYSTEM COVERAGE: PARENT MARKET 69
5.3 REGULATORY ANALYSIS 69
5.3.1 GLOBAL ALLIANCE FOR GENOMICS AND HEALTH (GA4GH) 69
5.4 VALUE CHAIN ANALYSIS 70
FIGURE 26 VALUE CHAIN: BIOINFORMATICS SERVICES WORKFLOW—
ANALYSIS PLAYS A CRUCIAL ROLE AFTER CORE SERVICES 70
5.5 SUPPLY CHAIN ANALYSIS 70
TABLE 4 SUPPLY CHAIN ECOSYSTEM 70
5.6 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 5 BIOINFORMATICS SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 72
5.6.1 THREAT OF NEW ENTRANTS 72
5.6.2 THREAT OF SUBSTITUTES 72
5.6.3 BARGAINING POWER OF SUPPLIERS 72
5.6.4 BARGAINING POWER OF BUYERS 72
5.6.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 72
5.7 COVID-19 IMPACT 73
6 BIOINFORMATICS SERVICES MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 6 BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 75
6.2 SEQUENCING SERVICES 76
TABLE 7 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 76
TABLE 8 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 76
TABLE 9 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 77
TABLE 10 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 77
TABLE 11 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 78
6.2.1 WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY 78
6.2.1.1 Launch of advanced whole-genome sequencing services to drive market growth 78
TABLE 12 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY, BY REGION,
2019–2026 (USD MILLION) 78
6.2.2 EXOME ANALYSIS 79
6.2.2.1 Rising awareness of exome analysis services to drive market growth 79
TABLE 13 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR EXOME ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 79
6.2.3 TRANSCRIPTOME ANALYSIS 79
6.2.3.1 Application of transcriptomics in diagnostics and cancer research is increasing 79
TABLE 14 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR TRANSCRIPTOME ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 80
6.2.4 METAGENOMIC ANALYSIS 80
6.2.4.1 Application of metagenomics in human microbiome analysis
to drive market growth 80
TABLE 15 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR METAGENOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 80
6.2.5 CHIP-SEQ ANALYSIS 81
6.2.5.1 Increasing awareness about the advantages of ChIP-seq among professionals to drive market growth 81
TABLE 16 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR CHIP-SEQ ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 81
6.2.6 OTHER SEQUENCING SERVICES 81
TABLE 17 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR OTHER SEQUENCING SERVICES, BY REGION, 2019–2026 (USD MILLION) 81
6.3 DATA ANALYSIS SERVICES 82
TABLE 18 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 19 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 83
TABLE 20 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 84
TABLE 21 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 84
TABLE 22 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 85
6.3.1 DATA MINING 85
6.3.1.1 Development of advanced bioinformatics applications and algorithms based on data mining to drive market growth 85
TABLE 23 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR DATA MINING,
BY REGION, 2019–2026 (USD MILLION) 85
6.3.2 GENOMIC ANALYSIS 86
6.3.2.1 Growth in the amount of sequencing data and technological advancements in genomic analysis to drive market growth 86
TABLE 24 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR GENOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 86
6.3.3 PROTEOMIC ANALYSIS 86
6.3.3.1 Increasing focus on personalized medicine and outsourcing of proteomic studies to drive market growth 86
TABLE 25 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 87
6.3.4 VARIANT ANNOTATION AND DISCOVERY 87
6.3.4.1 Increasing research on mutation analysis to drive market growth 87
TABLE 26 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR VARIANT ANNOTATION AND DISCOVERY, BY REGION, 2019–2026 (USD MILLION) 87
6.4 DRUG DISCOVERY SERVICES 88
6.4.1 ADVANCEMENTS IN PHARMACOGENOMICS TO DRIVE MARKET GROWTH 88
TABLE 27 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 88
TABLE 28 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
TABLE 29 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 89
TABLE 30 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 90
6.5 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES 90
6.5.1 R&D FOR THE ADVANCEMENT OF SOLUTIONS & SERVICES FOR DIFFERENTIAL GENE EXPRESSION STUDIES IS INCREASING 90
TABLE 31 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 91
TABLE 32 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 91
TABLE 33 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET,
BY END USER, 2019–2026 (USD MILLION) 92
TABLE 34 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET,
BY REGION, 2019–2026 (USD MILLION) 92
6.6 DATABASE AND MANAGEMENT SERVICES 92
6.6.1 GOVERNMENT INITIATIVES FOR DATA SHARING WILL DRIVE MARKET GROWTH 92
TABLE 35 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY SPECIALTY, 2019–2026 (USD MILLION) 93
TABLE 36 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 94
TABLE 37 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION) 94
TABLE 38 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 95
6.7 OTHER BIOINFORMATICS SERVICES 95
TABLE 39 OTHER BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 95
TABLE 40 OTHER BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 96
TABLE 41 OTHER BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 96
TABLE 42 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 96
7 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY 97
7.1 INTRODUCTION 98
TABLE 43 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 98
7.2 MEDICAL BIOTECHNOLOGY 98
7.2.1 USE OF BIOINFORMATICS SERVICES IS INCREASING IN MOLECULAR MEDICINE, DRUG DISCOVERY, AND CLINICAL DIAGNOSTICS 98
TABLE 44 BIOINFORMATICS SERVICES MARKET FOR MEDICAL BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 99
7.3 ANIMAL BIOTECHNOLOGY 99
7.3.1 VAST OMICS DATABASES FOR SEQUENCING & ANALYSIS OF ANIMAL GENOMIC DATA ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT 99
TABLE 45 BIOINFORMATICS SERVICES MARKET FOR ANIMAL BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 100
7.4 PLANT BIOTECHNOLOGY 100
7.4.1 DECREASING SEQUENCING COST AND ADVANCED BIOINFORMATICS SERVICES TO BOOST MARKET GROWTH 100
TABLE 46 BIOINFORMATICS SERVICES MARKET FOR PLANT BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 101
7.5 ENVIRONMENTAL BIOTECHNOLOGY 101
7.5.1 R&D OF BIOINFORMATICS IN ENVIRONMENTAL BIOTECHNOLOGY TO DRIVE MARKET GROWTH 101
TABLE 47 BIOINFORMATICS SERVICES MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION, 2019–2026 (USD MILLION) 102
7.6 FORENSIC BIOTECHNOLOGY 102
7.6.1 IMPROVED USE OF FORENSIC BIOINFORMATICS WILL
DRIVE MARKET GROWTH 102
TABLE 48 BIOINFORMATICS SERVICES MARKET FOR FORENSIC BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 103
8 BIOINFORMATICS SERVICES MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 49 BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 105
8.2 GENOMICS 105
8.2.1 GENOMICS IS THE LARGEST APPLICATION SEGMENT IN THE BIOINFORMATICS SERVICES MARKET 105
TABLE 50 BIOINFORMATICS SERVICES MARKET FOR GENOMICS, BY REGION,
2019–2026 (USD MILLION) 106
8.3 CHEMOINFORMATICS & DRUG DESIGN 106
8.3.1 PROACTIVE USE OF CHEMOINFORMATICS IN DRUG DISCOVERY BY PHARMACEUTICAL COMPANIES WILL DRIVE MARKET GROWTH 106
TABLE 51 BIOINFORMATICS SERVICES MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION, 2019–2026 (USD MILLION) 106
8.4 PROTEOMICS 107
8.4.1 R&D AND FINANCIAL SUPPORT FROM GOVERNMENT AND PRIVATE FUNDING BODIES IS INCREASING IN THE FIELD OF PROTEOMICS 107
TABLE 52 BIOINFORMATICS SERVICES MARKET FOR PROTEOMICS, BY REGION,
2019–2026 (USD MILLION) 107
8.5 TRANSCRIPTOMICS 108
8.5.1 INCREASING NUMBER OF RESEARCH STUDIES FOR THE TREATMENT OF CANCER USING TRANSCRIPTOMICS WILL SUPPORT MARKET GROWTH 108
TABLE 53 BIOINFORMATICS SERVICES MARKET FOR TRANSCRIPTOMICS, BY REGION, 2019–2026 (USD MILLION) 108
8.6 METABOLOMICS 108
8.6.1 TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF METABOLOMICS AND DATA ANALYSIS TO DRIVE MARKET GROWTH 108
TABLE 54 BIOINFORMATICS SERVICES MARKET FOR METABOLOMICS, BY REGION, 2019–2026 (USD MILLION) 109
8.7 OTHER APPLICATIONS 109
TABLE 55 BIOINFORMATICS SERVICES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 109
9 BIOINFORMATICS SERVICES MARKET, BY END USER 110
9.1 INTRODUCTION 111
TABLE 56 BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 111
9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS 111
9.2.1 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE THE LARGEST END USERS OF BIOINFORMATICS SERVICES 111
TABLE 57 BIOINFORMATICS SERVICES MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2019–2026 (USD MILLION) 113
9.3 HOSPITALS AND CLINICS 113
9.3.1 GROWING NUMBER OF COLLABORATIONS AND AGREEMENTS BETWEEN COMPANIES AND HOSPITALS TO BOOST MARKET GROWTH 113
TABLE 58 BIOINFORMATICS SERVICES MARKET FOR HOSPITALS AND CLINICS,
BY REGION, 2019–2026 (USD MILLION) 114
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 114
9.4.1 INCREASING FOCUS ON DEVELOPING TARGETED THERAPIES WILL DRIVE THE MARKET GROWTH 114
TABLE 59 BIOINFORMATICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 115
9.5 CONTRACT RESEARCH ORGANIZATIONS 115
9.5.1 INCREASING NUMBER OF CROS WILL ENHANCE THE MARKET GROWTH 115
TABLE 60 BIOINFORMATICS SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2026 (USD MILLION) 116
9.6 OTHER END USERS 116
TABLE 61 BIOINFORMATICS SERVICES MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 116
10 BIOINFORMATICS SERVICES MARKET, BY REGION 117
10.1 INTRODUCTION 118
TABLE 62 BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 118
10.2 NORTH AMERICA 119
FIGURE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET SNAPSHOT 120
TABLE 63 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 64 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 65 N0RTH AMERICA: BIOINFORMATICS SEQUENCING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 66 NORTH AMERICA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 67 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 123
TABLE 68 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
TABLE 69 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 124
10.2.1 US 124
10.2.1.1 Growing R&D activities in the US to drive market growth 124
TABLE 70 US: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 71 US: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 72 US: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
10.2.2 CANADA 126
10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of bioinformatics services 126
TABLE 73 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 74 CANADA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 75 CANADA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
10.3 EUROPE 128
TABLE 76 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 77 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 78 EUROPE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 79 EUROPE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 80 EUROPE: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 131
TABLE 81 EUROPE: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 82 EUROPE: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 132
10.3.1 GERMANY 132
10.3.1.1 Funding initiatives by the government will drive market growth 132
TABLE 83 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 84 GERMANY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 85 GERMANY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
10.3.2 UK 134
10.3.2.1 UK dominates the bioinformatics services market in Europe 134
TABLE 86 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 87 UK: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 88 UK: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
10.3.3 FRANCE 136
10.3.3.1 Government initiatives to support genomics research—a major factor driving market growth in France 136
TABLE 89 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 90 FRANCE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 91 FRANCE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Favorable funding scenario to drive the bioinformatics services market in Italy 137
TABLE 92 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 93 ITALY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 94 ITALY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
10.3.5 SPAIN 139
10.3.5.1 Increasing number of conferences focusing on new sequencing technologies and data analysis to support market growth 139
TABLE 95 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 96 SPAIN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 97 SPAIN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
10.3.6 REST OF EUROPE 141
TABLE 98 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 99 ROE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 100 ROE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
10.4 ASIA PACIFIC 142
FIGURE 28 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET SNAPSHOT 143
TABLE 101 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
TABLE 102 APAC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 103 APAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 104 APAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 105 APAC: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 145
TABLE 106 APAC: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
TABLE 107 APAC: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.4.1 JAPAN 146
10.4.1.1 Increasing focus on personalized diagnostics products to drive market growth in Japan 146
TABLE 108 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 109 JAPAN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 110 JAPAN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
10.4.2 CHINA 148
10.4.2.1 China is the largest market for bioinformatics services in APAC 148
TABLE 111 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 112 CHINA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 113 CHINA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
10.4.3 INDIA 150
10.4.3.1 Growing prevalence of target diseases in India to support market growth 150
TABLE 114 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 115 INDIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 116 INDIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
10.4.4 AUSTRALIA 152
10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth 152
TABLE 117 AUSTRALIA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 118 AUSTRALIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 119 AUSTRALIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
10.4.5 SOUTH KOREA 154
10.4.5.1 Supportive government initiatives expected to positively impact market growth 154
TABLE 120 SOUTH KOREA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 121 SOUTH KOREA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 122 SOUTH KOREA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 156
10.4.6 REST OF ASIA PACIFIC 156
TABLE 123 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 124 ROAPAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 125 ROAPAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
10.5 LATIN AMERICA 157
TABLE 126 LATAM: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 127 LATAM: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 128 LATAM: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 129 LATAM: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 130 LATAM: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 159
TABLE 131 LATAM: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
TABLE 132 LATAM: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 160
10.5.1 BRAZIL 160
10.5.1.1 Focus on NGS technologies and NGS data analysis is
increasing in Brazil 160
TABLE 133 BRAZIL: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 134 BRAZIL: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 135 BRAZIL: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
10.5.2 MEXICO 162
10.5.2.1 Economic growth in Mexico to support the growth of the market 162
TABLE 136 MEXICO: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 137 MEXICO: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 138 MEXICO: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
10.5.3 REST OF LATIN AMERICA 163
TABLE 139 ROLA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 140 ROLA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 141 ROLA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
10.6 MIDDLE EAST & AFRICA 165
10.6.1 INCREASING FOCUS ON GENOMICS RESEARCH TO DRIVE MARKET GROWTH IN MEA 165
TABLE 142 MEA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 143 MEA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 144 MEA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 145 MEA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 167
TABLE 146 MEA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 147 MEA: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 168
 
11 COMPETITIVE LANDSCAPE 169
11.1 OVERVIEW 169
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 169
11.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOINFORMATICS SERVICE PROVIDERS 170
11.4 REVENUE ANALYSIS 171
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET 171
11.5 MARKET SHARE ANALYSIS 171
FIGURE 30 THERMO FISHER SCIENTIFIC HELD THE LEADING POSITION IN THE BIOINFORMATICS SERVICES MARKET IN 2020 172
11.6 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 173
11.7 VENDOR INCLUSION CRITERIA 173
11.7.1 STARS 173
11.7.2 PERVASIVE PLAYERS 173
11.7.3 EMERGING LEADERS 174
11.7.4 PARTICIPANTS 174
FIGURE 31 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPANY
EVALUATION MATRIX, 2020 174
11.8 COMPANY EVALUATION QUADRANT (SMES/STRAT-UPS) 175
11.8.1 PROGRESSIVE COMPANIES 175
11.8.2 STARTING BLOCKS 175
11.8.3 RESPONSIVE COMPANIES 175
11.8.4 DYNAMIC COMPANIES 175
FIGURE 32 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2020 (SME/START-UPS) 176
11.9 COMPETITIVE BENCHMARKING 177
FIGURE 33 SERVICE AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET 177
TABLE 148 SERVICE FOOTPRINT OF COMPANIES 177
TABLE 149 REGIONAL FOOTPRINT OF COMPANIES 178
11.10 COMPETITIVE SCENARIO AND TRENDS 178
TABLE 150 BIOINFORMATICS SERVICES MARKET: SERVICE LAUNCHES,
JANUARY 2017–MAY 2021 178
TABLE 151 BIOINFORMATICS SERVICES MARKET: EXPANSIONS,
JANUARY 2017–MAY 2021 179
TABLE 152 BIOINFORMATICS SERVICES MARKET: DEALS, JANUARY 2017–MAY 2021 179
 
12 COMPANY PROFILES 181
12.1 KEY PLAYERS 181
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC 181
TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 181
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 182
TABLE 154 THERMO FISHER SCIENTIFIC: SERVICE OFFERINGS 182
TABLE 155 THERMO FISHER SCIENTIFIC: DEALS 183
TABLE 156 THERMO FISHER SCIENTIFIC: OTHER DEVELOPMENTS 184
12.1.2 EUROFINS SCIENTIFIC 186
TABLE 157 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 186
FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 187
TABLE 158 EUROFINS SCIENTIFIC: SERVICE OFFERINGS 187
TABLE 159 EUROFINS SCIENTIFIC: SERVICE LAUNCHES 188
TABLE 160 EUROFINS SCIENTIFIC: DEALS 188
12.1.3 ILLUMINA 190
TABLE 161 ILLUMINA: BUSINESS OVERVIEW 190
FIGURE 36 ILLUMINA: COMPANY SNAPSHOT 191
TABLE 162 ILLUMINA: SERVICE OFFERINGS 191
TABLE 163 ILLUMINA: DEALS 192
TABLE 164 ILLUMINA: OTHER DEVELOPMENTS 194
12.1.4 PERKINELMER 196
TABLE 165 PERKINELMER: BUSINESS OVERVIEW 196
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT 197
TABLE 166 PERKINELMER: SERVICE OFFERINGS 197
TABLE 167 PERKINELMER: SERVICE LAUNCHES 198
TABLE 168 PERKINELMER: DEALS 198
12.1.5 NEOGENOMICS 200
TABLE 169 NEOGENOMICS: BUSINESS OVERVIEW 200
FIGURE 38 NEOGENOMICS: COMPANY SNAPSHOT 200
TABLE 170 NEOGENOMICS: SERVICE OFFERINGS 201
TABLE 171 NEOGENOMICS: OTHER DEVELOPMENTS 201
12.1.6 BASECLEAR 202
TABLE 172 BASECLEAR: BUSINESS OVERVIEW 202
TABLE 173 BASECLEAR: SERVICE OFFERINGS 202
TABLE 174 BASECLEAR: SERVICE LAUNCHES 203
TABLE 175 BASECLEAR: DEALS 203
TABLE 176 BGI GROUP: BUSINESS OVERVIEW 204
TABLE 177 BGI GROUP: SERVICE OFFERINGS 205
TABLE 178 BGI GROUP: DEALS 206
12.1.8 CD GENOMICS 208
TABLE 179 CD GENOMICS: BUSINESS OVERVIEW 208
TABLE 180 CD GENOMICS: SERVICE OFFERINGS 208
12.1.9 FIOS GENOMICS 209
TABLE 181 FIOS GENOMICS: BUSINESS OVERVIEW 209
TABLE 182 FIOS GENOMICS: SERVICE OFFERINGS 209
TABLE 183 FIOS GENOMICS: DEALS 210
12.1.10 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY) 211
TABLE 184 GENEWIZ: BUSINESS OVERVIEW 211
FIGURE 39 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT 212
TABLE 185 GENEWIZ: SERVICE OFFERINGS 212
TABLE 186 GENEWIZ: SERVICE LAUNCHES 213
TABLE 187 GENEWIZ: DEALS 213
TABLE 188 GENEWIZ: OTHER DEVELOPMENTS 213
12.1.11 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN) 214
TABLE 189 PSOMAGEN, INC.: BUSINESS OVERVIEW 214
TABLE 190 PSOMAGEN: SERVICE OFFERINGS 214
TABLE 191 PSOMAGEN: DEALS 216
TABLE 192 PSOMAGEN: OTHER DEVELOPMENTS 216
12.1.12 MEDGENOME LABS 217
TABLE 193 MEDGENOME: BUSINESS OVERVIEW 217
TABLE 194 MEDGENOME: SERVICE OFFERINGS 217
12.1.13 MICROSYNTH 218
TABLE 195 MICROSYNTH: BUSINESS OVERVIEW 218
TABLE 196 MICROSYNTH: SERVICE OFFERINGS 218
TABLE 197 MICROSYNTH: SERVICE LAUNCHES 219
12.1.14 QIAGEN N.V. 220
TABLE 198 QIAGEN N.V.: BUSINESS OVERVIEW 220
FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT 221
TABLE 199 QIAGEN N.V.: SERVICE OFFERINGS 221
TABLE 200 QIAGEN N.V.: DEALS 222
TABLE 201 QIAGEN N.V.: OTHER DEVELOPMENTS 223
12.1.15 SOURCE BIOSCIENCE 224
TABLE 202 SOURCE BIOSCIENCE: BUSINESS OVERVIEW 224
FIGURE 41 SOURCE BIOSCIENCE: COMPANY SNAPSHOT 225
TABLE 203 SOURCE BIOSCIENCE: SERVICE OFFERINGS 225
12.2 OTHER COMPANIES 227
12.2.1 NXT-DX (A DIAGENODE COMPANY) 227
12.2.2 NUCLEOME BIOINFORMATICS 228
12.2.3 1010GENOME 229
12.2.4 DNANEXUS, INC. 229
12.2.5 BIONIVID 230
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 231
13.1 DISCUSSION GUIDE 231
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 236
13.3 AVAILABLE CUSTOMIZATIONS 238
13.4 RELATED REPORTS 238
13.5 AUTHOR DETAILS 239

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127